Download Flash player to listen to The return of genetic results: Part I
Download Flash player to listen to The return of genetic results: Part II
Download Flash player to listen to The return of genetic results: Part III
Image: George Gastin via WikimediaAs genomic science evolves in an age of increasingly rapid and cheap gene sequencing, more large-scale genetic studies are enlisting thousands of human subjects, who are lending their tissue samples for researchers to probe for the signals of cancer, Alzheimer's or other complex conditions. But as science constructs a clearer picture of how genes affect human health, and study participants become more curious about what their genomes can tell them, an important
Download Flash player to listen to The return of genetic results: Part I
Download Flash player to listen to The return of genetic results: Part II
Download Flash player to listen to The return of genetic results: Part III


From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.

Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes